Radonjic D - Search Results

1

Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives.

Reck M, Popat S, Grohé C, Corral J, Novello S, Gottfried M, Brueckl W, Radonjic D, Kaiser R, Heymach J. Reck M, et al. Among authors: radonjic d. Lung Cancer. 2023 May;179:107173. doi: 10.1016/j.lungcan.2023.03.009. Epub 2023 Mar 15. Lung Cancer. 2023. PMID: 36940614 Review.

2

Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?

Popat S, Grohé C, Corral J, Reck M, Novello S, Gottfried M, Radonjic D, Kaiser R. Popat S, et al. Among authors: radonjic d. Lung Cancer. 2020 Jun;144:76-84. doi: 10.1016/j.lungcan.2020.04.009. Epub 2020 Apr 20. Lung Cancer. 2020. PMID: 32387684 Free article. Review.

3

Non-interventional LUME-BioNIS study of nintedanib plus docetaxel after chemotherapy in adenocarcinoma non-small cell lung cancer: A subgroup analysis in patients with prior immunotherapy.

Reck M, Syrigos K, Miliauskas S, Zöchbauer-Müller S, Fischer JR, Buchner H, Kitzing T, Kaiser R, Radonjic D, Kerr K. Reck M, et al. Among authors: radonjic d. Lung Cancer. 2020 Oct;148:159-165. doi: 10.1016/j.lungcan.2020.08.004. Epub 2020 Aug 8. Lung Cancer. 2020. PMID: 32927350 Free article.

4

Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial after first-line chemotherapy failure in NSCLC.

Westeel V, Schuette W, Urban T, Radonjic D, von Wangenheim U, Lorence RM, Reck M. Westeel V, et al. Among authors: radonjic d. PLoS One. 2023 Oct 17;18(10):e0292307. doi: 10.1371/journal.pone.0292307. eCollection 2023. PLoS One. 2023. PMID: 37847688 Free PMC article. Clinical Trial.

5

Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.

Vormittag L, Lemaire C, Radonjic D, Kornek G, Selzer E. Vormittag L, et al. Among authors: radonjic d. Strahlenther Onkol. 2012 Mar;188(3):235-42. doi: 10.1007/s00066-011-0040-9. Epub 2012 Feb 10. Strahlenther Onkol. 2012. PMID: 22318328 Clinical Trial.

6

Genetic Diversity of Montenegrin Local Sheep Breeds Based on Microsatellite Markers.

Marković M, Radonjić D, Zorc M, Đokić M, Marković B. Marković M, et al. Among authors: radonjic d. Animals (Basel). 2022 Nov 3;12(21):3029. doi: 10.3390/ani12213029. Animals (Basel). 2022. PMID: 36359153 Free PMC article.

7

Differentiation of some Pramenka sheep breeds based on morphometric characteristics.

Marković B, Dovč P, Marković M, Radonjić D, Adakalić M, Simčič M. Marković B, et al. Among authors: radonjic d. Arch Anim Breed. 2019 Jul 10;62(2):393-402. doi: 10.5194/aab-62-393-2019. eCollection 2019. Arch Anim Breed. 2019. PMID: 31807650 Free PMC article.

8

Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab.

Selzer E, Liederer S, Lemaire C, Kren G, Radonjic D, Kornek G, Knocke T, Pötter R, Bachtiary B. Selzer E, et al. Among authors: radonjic d. Strahlenther Onkol. 2011 Jun;187(6):373-7. doi: 10.1007/s00066-011-2217-7. Epub 2011 May 16. Strahlenther Onkol. 2011. PMID: 21603990

9

[Fibrin glue in tympanoplasty].

Ristić B, Radonjić D, Haralampiev K, Milenković L. Ristić B, et al. Among authors: radonjic d. Vojnosanit Pregl. 1990 May-Jun;47(3):190-3. Vojnosanit Pregl. 1990. PMID: 2219803 Serbian.

10

[The significance of dystrophic changes in traumatic facial nerve paralysis].

Ristić B, Doković V, Radonjić D, Haralampiev K. Ristić B, et al. Among authors: radonjic d. Vojnosanit Pregl. 1989 May-Jun;46(3):163-7. Vojnosanit Pregl. 1989. PMID: 2815628 Serbian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page